NU
Nuvation Bio
NUVB13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying NUVB
Top funds mostly trimmed Nuvation Bio in Q1 (Jan–Mar)
Buying:
FundsInsidersCongress
- Top funds0 of 2 bought more, 1 sold some. Largest: Abrams Capital Management, $7.2M (0% of its portfolio).
- Insiders1 insider bought, 14 sales in 12 months.
- CongressNo trades disclosed in the last 12 months.
2 funds$7.4M held0.1% avg. weightQ1: 0 bought / 1 sold
13F reports are a snapshot as of Mar 31, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Congressional trading
Last 2 years · 0 disclosed trades
| Date | Member | Type | Amount | |
|---|---|---|---|---|
| No congressional trades match this filter. | ||||